Joint

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Joint (JYNT) posts record sales in Q4 2022, eyes strategic growth

Joint (JYNT) delivered strong financial performance in Q4 2022, driven by record clinic openings and successful marketing initiatives.
While facing challenges such as labor costs and franchise sales impact, the company is focused on margin expansion and strategic growth opportunities.
With a positive outlook for 2023 revenue and adjusted EBITDA, Joint (JYNT) aims to navigate challenges and capitalize on opportunities for sustained success.
The company's commitment to patient care, operational efficiency, and financial planning positions it well for future growth and profitability.

Joint Corp. posts impressive Q1 results amidst digital marketing evolution

Joint Corp. delivered robust Q1 2023 results with strong sales growth and operational performance across its clinic network.
While facing competitive pressures and marketing challenges, the company's focus on efficiency and patient acquisition strategies bodes well for future growth.
Adapting to digital marketing trends and leveraging upcoming events can position Joint Corp. for sustained success and investor confidence.

Joint (JYNT) reports strong Q2 growth, focuses on profitability

Joint (JYNT) reported solid growth in system-wide sales and clinic openings, with profitability around 20% despite challenges.
The company is actively addressing operational issues, optimizing its clinic portfolio, and focusing on cost savings initiatives.
Strategic planning for profitability and efficiency in 2024 and beyond is underway, with a commitment to long-term success.
Partnerships, marketing expansions, and ongoing reviews present opportunities for growth and market expansion for Joint (JYNT).

The Joint Corp. reports stable Q3 earnings, shifts focus to franchises

The Joint Corp. delivered solid financial performance in Q3 2023, with a focus on refranchising and enhancing franchise clinic operations.
Efforts to boost new patient starts and optimize marketing strategies are driving positive trends in conversion rates and sales.
While facing challenges in new patient counts and franchise sales, the company is strategically positioning itself for long-term success.

The Joint Corp. reports robust 2023 performance and strategic growth plans

The Joint Corp. delivered strong financial performance in 2023, with notable growth in sales, revenue, and patient metrics.
Strategic initiatives like refranchising and local store marketing offer growth opportunities and cost-saving potential for the company.
Challenges include managing the transition of company-owned clinics and balancing marketing expenses with revenue growth objectives.
Overall, The Joint Corp. is well-positioned to capitalize on its operational strengths and market opportunities for sustained growth and success.

The Joint Corp. triples franchise sales and boosts financial performance

The Joint Corp. delivered strong financial performance in Q1 2024, marked by revenue growth, improved bottom line, and significant franchise sales growth, supported by robust marketing strategies.
While facing potential risks and challenges, the company's focus on EBITDA, franchise expansion, and talent development positions it well for future growth and operational excellence.
Opportunities in marketing innovation, talent development, and operational efficiency present avenues for sustained growth and value creation, aligning with the company's commitment to performance and brand enhancement.
Overall, The Joint Corp.'s Q1 2024 earnings call highlighted a strategic roadmap for success, emphasizing growth, excellence in patient care, and financial transparency to drive shareholder value.

The Joint Corp. reports revenue growth and strategic focus on clinics

The Joint Corp. reported positive revenue growth in Q2 2024, driven by same-store comps and operational improvements.
While facing financial challenges and impact on franchise sales, the company's strategic focus on clinic optimization and patient loyalty is a key strength.
Future opportunities lie in expanding the clinic network, enhancing profitability, and driving patient loyalty through innovative strategies.
Overall, The Joint Corp. is positioned for growth with a strong foundation of clinics and a focus on improving financial performance and patient experiences.

Joint Corp (JYNT) reports robust Q3 performance amidst operational enhancements

Joint Corp's Q3 2024 earnings call highlighted strong performance metrics, a strategic focus on patient care and operational efficiency, and challenges related to consumer headwinds and refranchising efforts. The company is well-positioned to capitalize on growth opportunities by leveraging its infrastructure and exploring new service offerings.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Increases Corporate Clinic Count to 63 as of July 1, 2020 Increases Corporate Clinic Count to 63 as of July 1, 2020

The Joint Corp. Opens Two Corporately Managed Greenfield Clinics

SCOTTSDALE, Ariz., June 2, 2020 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, wants to help get America moving by offering a free initial visit to all new patients throughout the month of June,...

The Joint Chiropractic Pledges Free New Patient Visits in June Worth About $1 Million to Help Americans Get Moving

The Joint Corp. (JYNT) CEO Peter Holt on Q1 2020 Results - Earnings Call Transcript

- Commits to keeping clinics open when and where possible during the crisis -

The Joint Chiropractic is an Essential Healthcare Service

The Joint Corp's (JYNT) CEO Peter Holt on Q4 2019 Results - Earnings Call Transcript

The Joint Corp. (JYNT) delivered earnings and revenue surprises of 12.50% and 4.09%, respectively, for the quarter ended December 2019.

The Joint Corp. (JYNT) Surpasses Q4 Earnings and Revenue Estimates

SCOTTSDALE, Ariz., March  03, 2020  (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, closed a senior secured credit facility with J.P. Morgan Chase Bank, N.A. for $7.5 million, including a $5.5 million development line of credit (LOC) and a $2.0 million revolving LOC, which has an uncommitted accordion feature for an additional $2.5 million. The company repaid its previous LOC prior to December 31, 2019.

The Joint Corp. Secures $7.5 Million Line of Credit with J.P.

The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

The Joint Corp. (JYNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Select Medical Holdings

UnitedHealth Group

HMO players are poised for growth on the back of higher revenues, membership growth, technological advancements and a solid capital position.

3 HMO 2019 Outperformers Likely to Retain Beat Streak in 2020

ACM Research

Lithium Americas Corp

Talos Energy Inc

Investors always look for companies with a high level of profitability regardless of the present market condition.

Four Profitable Stocks to Boost Returns Using Net Income Ratio

- Grows System-Wide Sales 33% Annually, Compared to 2018 - - Increases Franchise Licenses Sales to 126, Up from 99 in 2018 -

The Joint Corp. Provides 2019 Metrics and New Clinic Guidance for 2020

The Joint Corp's (JYNT) CEO Peter Holt on Q3 2019 Results - Earnings Call Transcript

Recent esoteric exhibits to 8-K disclosures from The Joint point to an unraveling of the growth story.

Joint Franchise Repurchases Are 'Franchise 101' Red Flag

Ensign Group

Fulgent Genetics

NeoGenomics

Volitionrx Limited

These healthcare stocks are all worth a "buy" now. The healthcare sector will keep chugging along despite market volatility.

7 Next-Generation Healthcare Stocks to Buy

SCOTTSDALE, Ariz., Sept.  19, 2019  (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will present at the 5th Annual B. Riley FBR Consumer & Media Conference on Thursday, October 3, 2019 at the Sofitel Hotel in New York City. 

The Joint Corp. to Present at the 5th Annual B.

SCOTTSDALE, Ariz., Sept.  03, 2019  (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management is scheduled to attend the Lake Street Capital Markets 2019 Annual Best Ideas Growth Conference on Thursday, September 12th.  The conference is being held at the Parker Hotel in New York City. 

The Joint Corp. to Participate in the Lake Street Capital Markets 2019 Annual Best Ideas Growth Conference

The Joint Corp. is an open-clinic chiropractic franchising firm.

The Joint Corp: From A $2 Stock To $17 In Less Than Three Years And More Growth In The Horizon

The Joint Corp.: From A $2 Stock To $17 In Less Than 3 Years And More Growth On The Horizon

Molina Healthcare

MOH vs. JYNT: Which Stock Is the Better Value Option?

MOH vs. JYNT: Which Stock Should Value Investors Buy Now?

- Corporate Owned and Managed Portfolio Increases to 58 - - Corporate Owned and Managed Portfolio Increases to 58 -

The Joint Corp. Acquired Additional Clinic in the San Diego Market

The Joint Corp. (JYNT) delivered earnings and revenue surprises of 50.00% and 0.79%, respectively, for the quarter ended June 2019.

The Joint Corp. (JYNT) Beats Q2 Earnings and Revenue Estimates

The Joint Corp. (JYNT) closed the most recent trading day at $17.50, moving +0.34% from the previous trading session.

The Joint Corp. (JYNT) Gains As Market Dips: What You Should Know

The Joint Corp. (JYNT) closed the most recent trading day at $15.94, moving -1.48% from the previous trading session.

News for Joint Stock (JYNT)